[Form 4] Hilltop Holdings Inc. Insider Trading Activity
Rhea-AI Filing Summary
Steve B. Thompson, PrimeLending President and CEO and a reporting person for Hilltop Holdings Inc. (HTH), was granted 9,917 restricted stock units on 02/23/2021. Those units will convert into an equal number of shares of Hilltop common stock upon vesting on the third anniversary of the grant, 02/23/2024, or earlier if specified award events occur. Shares deliverable upon conversion are subject to transfer restrictions until the first anniversary of the vesting date, 02/23/2025, unless earlier events permit release. After this grant the reporting person beneficially owned 43,919 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Grant of 9,917 restricted stock units to the reporting person on 02/23/2021 is explicitly disclosed
- Clear vesting schedule: units vest on 02/23/2024 (third anniversary) as stated
- Post-vesting transfer restrictions specified until 02/23/2025, providing clarity on share liquidity
- Total beneficial ownership reported as 43,919 shares after the grant
Negative
- None.
Insights
TL;DR: A standard executive retention grant of 9,917 RSUs with multi-year vesting and post-vesting transfer restrictions.
This filing documents a time-based equity award made to a named executive officer that vests in three years and imposes a one-year transfer restriction after vesting. Such structures are commonly used to retain management and align their interests with shareholders over a multi-year horizon. The filing clearly states the number of units, vesting date, and post-vesting transfer restriction date, and reports total beneficial ownership following the grant as 43,919 shares. No additional compensation amounts, cash payments, or derivative transactions are reported here.
TL;DR: Filing appears routine and compliant, disclosing a grant and related ownership positions without additional material events.
The Form 4 identifies the reporting person, relationship to the issuer, transaction date, grant quantity, and the specific vesting and restriction timelines stated in the explanatory footnote. The signature block shows the form was signed by an attorney-in-fact. The disclosure meets Section 16 reporting elements present in the document and contains no information about exercises, sales, or dispositions that would suggest trading activity beyond the award.